One of the main challenges remains that diagnostics and drugs for people suffering from advanced HIV aren’t readily available. This group of people is vulnerable to deadly opportunistic infections.
More than 250 000 patients at highest risk for cryptococcal meningitis but no symptoms will be screened in South Africa annually to reduce the number of deaths.